Stay updated with breaking news from Ovarian Malignancy Algorithm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An advanced blood test is set to be offered to patients experiencing ovarian cancer symptoms at a few select health-care facilities in the U.K., in a new trial that researchers hope could revolutionize the way we diagnose this dangerous disease.
An advanced blood test is set to be offered to patients experiencing ovarian cancer symptoms at a few select health-care facilities in the U.K., in a new trial that researchers hope could revolutionize the way we diagnose this dangerous disease.
ANGLE plc: Angle PLC- Ovarian Cancer Study Patient Enrolment Completed Headline results from the Study expected in Q4 2021 Study designed to support launch of an ovarian cancer test from ANGLE's clinical laboratories in the United States and the UK GUILDFORD, SURREY, UK / ACCESSWIRE / April 26, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that its 200 patient ovarian cancer clinical verification study ("the Study") has completed patient enrolment. The Study, undertaken by the University of Rochester Medical Center Wilmot Cancer Institu...